HotSpot Therapeutics

OverviewSuggest Edit

HotSpot Therapeutics is a company that discovers allosteric therapies. It develops SpotFinder technology platform for understanding of protein structure-function, which systematically opens up the allosteric sites used naturally to control the proteins. It enables structural, druggability and functional insights to disclose proteins.

TypePrivate
Founded2017
HQBoston, MA, US
Websitehotspotthera.com

Latest Updates

Employees (est.) (Jan 2022)53(+13%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at HotSpot Therapeutics

Michael Tota

Michael Tota

Vice President, Biology
Jonathan Montagu

Jonathan Montagu

Co-Founder and Chief Executive Officer, Director
Geraldine Harriman

Geraldine Harriman

Co-Founder and Chief Scientific Officer
R. Aldrin Denny

R. Aldrin Denny

Vice President, Head of Computational Sciences
Kenneth Carson

Kenneth Carson

Executive Vice President, Head of Chemical Sciences
Eva Jack

Eva Jack

Chief Operating Officer
Show more

HotSpot Therapeutics Office Locations

HotSpot Therapeutics has an office in Boston
Boston, MA, US (HQ)
50 Milk St 16th floor
Show all (1)

HotSpot Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

HotSpot Therapeutics total Funding

$110 m

HotSpot Therapeutics latest funding size

$65 m

Time since last funding

2 years ago

HotSpot Therapeutics investors

HotSpot Therapeutics's latest funding round in May 2020 was reported to be $65 m. In total, HotSpot Therapeutics has raised $110 m
Show all financial metrics

HotSpot Therapeutics Acquisitions / Subsidiaries

Company NameDateDeal Size
MacroceuticsAugust 23, 2019

HotSpot Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

HotSpot Therapeutics Online and Social Media Presence

Embed Graph

HotSpot Therapeutics News and Updates

HotSpot Therapeutics and Caris Life Sciences Announce Collaboration to Advance Precision Medicine Development for Difficult-to-Drug Therapeutic Targets

BOSTON, Jan. 10, 2022 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first- and best-in-class allosteric therapies targeting regulatory sites on proteins referred to as "natural hotspots," and Caris Life Sciences® (Caris),...

Caris Life Sciences and HotSpot Therapeutics Announce Collaboration to Advance Precision Medicine Development for Difficult-to-Drug Therapeutic Targets

IRVING, Texas, Jan. 10, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, and HotSpot Therapeutics, Inc., a biotechnology company pioneering the...

HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic

BOSTON, Nov. 29, 2021 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first-in-class allosteric therapies targeting regulatory sites on proteins referred to as "natural hotspots," today announced the close of its...

HotSpot Therapeutics Blogs

Making R&D ‘Smarter’ by Putting Artificial Intelligence into Practice

The pharmaceutical industry still faces unrelenting challenges across the entirety of the drug development landscape. According to Piper Sandler’s recent […] The post Making R&D ‘Smarter’ by Putting Artificial Intelligence into Practice appeared first on HotSpot Therapeutics.

Reimagining the Workplace Post Pandemic

Returning to work following the pandemic presents an opportunity to think creatively about how to re-configure the workplace The post Reimagining the Workplace Post Pandemic appeared first on HotSpot Therapeutics.

The Business of Science

Today marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it also marks a […] The post The Business of Science appeared first on HotSpot Therapeutics.

HotSpot Therapeutics Frequently Asked Questions

  • When was HotSpot Therapeutics founded?

    HotSpot Therapeutics was founded in 2017.

  • Who are HotSpot Therapeutics key executives?

    HotSpot Therapeutics's key executives are Michael Tota, Jonathan Montagu and Geraldine Harriman.

  • How many employees does HotSpot Therapeutics have?

    HotSpot Therapeutics has 53 employees.

  • Who are HotSpot Therapeutics competitors?

    Competitors of HotSpot Therapeutics include Olio, AmacaThera and Precision BioSciences.

  • Where is HotSpot Therapeutics headquarters?

    HotSpot Therapeutics headquarters is located at 50 Milk St 16th floor, Boston.

  • Where are HotSpot Therapeutics offices?

    HotSpot Therapeutics has an office in Boston.

  • How many offices does HotSpot Therapeutics have?

    HotSpot Therapeutics has 1 office.